O'Neil Global Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-825
Closed -$269K 70
2024
Q1
$269K Buy
+825
New +$203K 0.33% 23
2023
Q3
Sell
-40,273
Closed -$11.5M 105
2023
Q2
$11.5M Buy
+40,273
New +$11.2M 2.38% 12
2022
Q4
Sell
-6,960
Closed -$1.94M 60
2022
Q3
$1.94M Sell
6,960
-3,212
-32% -$817K 7.67% 2
2022
Q2
$1.95M Buy
10,172
+6,272
+161% +$1.11M 8.26% 3
2022
Q1
$809K Buy
+3,900
New +$643K 0.42% 36
2021
Q4
Sell
-2,073
Closed -$427K 106
2021
Q3
$427K Buy
+2,073
New +$407K 0.33% 56

Other funds holding SWAV

O'Neil Global Advisors's SWAV Position: Q2 2024 in Review

O'Neil Global Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 825 shares — an estimated $269K sold.

O'Neil Global Advisors first reported a position in SWAV in Q3 2021 and held it in 6 quarters. The position peaked at $11.5M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • O'Neil Global Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • O'Neil Global Advisors sold 825 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $269K.
  • O'Neil Global Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • O'Neil Global Advisors's Shockwave Medical, Inc. Common Stock position peaked at $11.5M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on O'Neil Global Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.